Molecular Docking and Identification of Candidate Blockers for Endonuclease Domain of Lassa Virus Polymerase as Potential Drugs

Molecular Docking and Identification of Candidate Blockers for Endonuclease Domain of Lassa Virus Polymerase as Potential Drugs

Lassa fever is a deadly hemorrhagic disease virus caused by Lassa virus (LASV) which is a member of the Arenaviridae virus family. Lassa virus-encoded L polymerase is required for the replication and transcription of the RNA virus. There is no available vaccine as ribavirin remains the only treatme...

Full description

Bibliographic Details
Main Authors:	J.B. Minari, E.E. Agho, F.D. Adebiyi, O.O. Rotimi, B.O. Sholaja, J. Adejumo
Format:	Article
Language:	English
Published:	Joint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP) 2022-02-01
Series:	Journal of Applied Sciences and Environmental Management
Online Access:	https://www.ajol.info/index.php/jasem/article/view/221233

Similar Items

High-resolution structure of the N-terminal endonuclease domain of the Lassa virus L polymerase in complex with magnesium ions.
by: Gregor D Wallat, et al.
Published: (2014-01-01)

Review of candidate vaccines for the prevention of Lassa fever
by: O. D. Popova, et al.
Published: (2021-05-01)

Conserved Endonuclease Function of Hantavirus L Polymerase
by: Sylvia Rothenberger, et al.
Published: (2016-05-01)

Advanced Vaccine Candidates for Lassa Fever
by: Igor S. Lukashevich
Published: (2012-10-01)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
by: Cashman Kathleen A, et al.
Published: (2010-10-01)

Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor
by: Xin Meng, et al.
Published: (2021-12-01)

Modeling the dynamics of Lassa fever in Nigeria
by: Mayowa M. Ojo, et al.
Published: (2021-07-01)

Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.
by: Yuan, P, et al.
Published: (2009)

Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever
by: O. Popova, et al.
Published: (2025-01-01)

Mathematical Modelling and Analysis of Transmission Dynamics of Lassa Fever
by: E. A. Bakare, et al.
Published: (2020-01-01)

Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines
by: Hannah Murphy, et al.
Published: (2022-10-01)

Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
by: Weimei Xing, et al.
Published: (2017-01-01)

An AP endonuclease 1-DNA polymerase beta complex: theoretical prediction of interacting surfaces.
by: Alexej Abyzov, et al.
Published: (2008-04-01)

Dealing with the unseen: Ffear and stigma in lassa fever
by: D. Asogun, et al.
Published: (2014-04-01)

Development and Testing of the Method for the Detection of Lassa virus RNA, Based on real-Time Polymerase Chain reaction with reverse Transcription
by: V. G. Dedkov, et al.
Published: (2018-12-01)

Lassa fever in West African sub-region: an overview
by: O. Ogbu, et al.
Published: (2007-01-01)

Aseptic Meningitis Caused by Lassa Virus: Case Series Report
by: Peter O. Okokhere, et al.
Published: (2016-01-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
by: Meirong Wang, et al.
Published: (2021-03-01)

Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus
by: Demetrius Matassov, et al.
Published: (2024-07-01)

Lassa fever outbreak investigation in a Nigerian bakery - August, 2012
by: A.O. Ogunniyi, et al.
Published: (2014-04-01)

Pathogenesis of Lassa Fever
by: David H. Walker, et al.
Published: (2012-10-01)

Molecular docking and molecular dynamics simulation studies of inhibitor candidates against Anopheles gambiae 3-hydroxykynurenine transaminase and implications on vector control
by: Eunice O. Adedeji, et al.
Published: (2025-01-01)

Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage.
by: Harris, J, et al.
Published: (2009)

Modular probe-based colorimetric miRNA detection via polymerase/endonuclease assisted chain displacement
by: Xialing Xu, et al.
Published: (2024-08-01)

Selective RNA Labeling by RNA-Compatible Type II Restriction Endonuclease and RNA-Extending DNA Polymerase
by: Hyesung Jo, et al.
Published: (2022-10-01)

Preparation of 5'-O-(1-Thiotriphosphate)-modified oligonucleotides using polymerase-endonuclease amplification reaction (PEAR).
by: Biao Li, et al.
Published: (2013-01-01)

Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase
by: Ao Hu, et al.
Published: (2020-02-01)

Restriction endonucleases /
by: 407908 Pingoud, Alfred M.
Published: (2004)

A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs
by: Brian D. Carey, et al.
Published: (2024-11-01)

Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1-/- Mice
by: Dylan M. Johnson, et al.
Published: (2019-01-01)

A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
by: Yingyun Cai, et al.
Published: (2020-04-01)

Identification of co-circulating pathogens that are clinically indistinguishable from Lassa fever during the 2018 Lassa outbreak in Nigeria
by: J. Ashcroft, et al.
Published: (2020-12-01)

Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.
by: Juan Carlos Zapata, et al.
Published: (2013-01-01)

Immunological screening of Lassa virus among health workers and contacts of patients of Lassa fever in Ondo State
by: Shaibu, JO, et al.
Published: (2021)

Lassa fever in Nigeria: epidemiology and risk perception
by: Ahmad I Al-Mustapha, et al.
Published: (2024-11-01)

Sensorineural hearing loss in Lassa fever: two case reports
by: Okokhere Peter O, et al.
Published: (2009-01-01)

One-Year Retrospective Review of Psychiatric Consultations in Lassa Fever, Southern Nigeria
by: Esther O. Okogbenin, et al.
Published: (2020-12-01)

Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)
by: Duvignaud, A, et al.
Published: (2020)

Lassa virus protein–protein interactions as mediators of Lassa fever pathogenesis
by: Sharon Jan, et al.
Published: (2025-02-01)

Docking Studies of Phthalimide Pharmacophore as a Sodium Channel Blocker
by: Maryam Iman, et al.
Published: (2013-09-01)